Biotech Innovations Accelerate Placenta Market Growth in Nutraceuticals and Cosmeceuticals
The global placenta market is experiencing significant growth, with projections indicating an increase from USD 652.21 million in 2025 to approximately USD 1,404.87 million by 2034, reflecting a compound annual growth rate (CAGR) of 8.9% during the forecast period.
Market
Overview
Placental-derived
products have gained prominence across various industries due to their rich
composition of bioactive compounds, including growth factors, hormones, and
proteins. These components contribute to the therapeutic and cosmetic benefits
of placenta-based products, leading to increased adoption in pharmaceuticals,
cosmetics, and nutraceuticals.
Market
Segmentation
By
Type:
- Porcine
Placenta: Derived
from pigs, porcine placenta is rich in growth factors and proteins, making
it highly valued in both pharmaceuticals and cosmetics. Its regenerative
properties are utilized in skin regeneration and anti-aging products.
- Equine
Placenta: Sourced
from horses, equine placenta is primarily used in premium cosmetic
products and therapeutic treatments. It is appreciated for its high levels
of growth factors and amino acids that enhance skin rejuvenation and
repair.
- Ovine
Placenta: Obtained
from sheep, ovine placenta is utilized in various applications due to its
beneficial properties.
By
Application:
- Pharmaceuticals: Placental extracts are explored
for their therapeutic properties, including liver function improvement and
treatment of menopausal symptoms.
- Cosmetics: The anti-aging and skin
rejuvenation properties of placenta extracts have led to their
incorporation in skincare products.
- Nutraceuticals: Placenta-based supplements are
gaining popularity for their potential health benefits.
Country-wise
Market Trends
United
States
The
United States placenta market is experiencing steady growth, driven by advanced
maternal healthcare infrastructure, early adoption of biomarker-based
diagnostics, and robust clinical research support. The market is expected to
expand at a CAGR of around 6.8% from 2025 to 2035.
United
Kingdom
The
UK's placenta market is estimated to grow at a CAGR of approximately 6.5% from
2025 to 2035. The National Health Service (NHS) could greatly influence demand
by introducing placental biomarkers into its antenatal screening protocols.
South
Korea
South
Korea's placenta market is expected to expand at a CAGR of 6.7% from 2025 to
2035. The country's rapidly aging maternal population and rising incidence of
gestational hypertension create a strong case for placental growth factor test
adoption.
Brazil
The
Brazil placenta market is projected to exhibit a growth rate (CAGR) of 9.2%
during 2025-2033. The market is experiencing significant growth due to the
increasing demand for placenta-based products in the cosmetics industry,
continual advancements in research and development (R&D) activities, and
the growing popularity of natural health solutions.
Conclusion
The
global placenta
market is poised for substantial growth, driven by increasing demand across
pharmaceuticals, cosmetics, and nutraceuticals. Advancements in research and
development, coupled with rising consumer awareness of the benefits of
placenta-derived products, are expected to further propel market expansion in
the coming years.
More
Trending Latest Reports By Polaris Market Research:
Warehouse
Automation Market - update
U.S.
Industrial Microwave Heating Market
Distributed
Antenna System (DAS) Market
Comments
Post a Comment